We are monitoring the impact of COVID-19 on Non-Invasive Prenatal Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2700
Share on
Share on

Global Non-Invasive Prenatal Testing Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Instruments, Method, Application & Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2700
Pages: 176

Global Non-Invasive Prenatal Testing Market Size (2021 to 2026)

The size of the global non-invasive prenatal testing market is estimated to be growing at a CAGR of 15.6% during the forecast period. The market size is predicted to be USD 4.65 billion by 2026 from USD 2.25 billion in 2021.

Various industries of various regions manage this Non-Invasive Prenatal Testing (NIPTherefore, The study of NIPT is a combination of qualitative and quantitative, highlighting the market developments, challenges, opportunities, and analyses available and trends in NIPT.

MARKET DRIVERS:

Growth in reimbursements for the NIPT sector and maternal age growth, the development of acquiring technologies, and non-invasive parental testing products are a few of the significant factors driving the global non-invasive prenatal testing market growth.

Serving regulatory procedures, which take more time to approve new products, and the rapid development of a new device method are the factors that restrict the market growth. Lack of having expert professionals and strict regular guidelines that slows down the process of approvals and marketing are other attributes degrading the demand of the Global Non-Invasive Prenatal Testing Market.

Advance genome sequencing technology turnaround time and the complexity of diagnosis with the next-generation sequencing create growth opportunities for the Non-Invasive Prenatal Testing Market. NGS technology provides many opportunities to develop non-invasive diagnostic procedures for the early and correct detection of various genetic disorders.

MARKET RESTRAINTS:

Meticulous primary and secondary research techniques and data analysis, including qualitative and quantitative research of analysts, directly impede the demand of the non-invasive prenatal testing market. Positive results would require a test with the help of invasive methods such as CVS and amniocentesis, which pose a significant challenge for the Global NIPT market.

Impact of COVID-19 on Non-Invasive Prenatal Testing Market:

Non-invasive prenatal testing (NIPT) services have been halted to avoid the spread of the COVID-19 virus; the outbreak is expected to affect the non-invasive prenatal testing market. Non-invasive prenatal testing (NIPT), also known as cell-free DNA testing, is a useful addition to the variety of screening tests available to detect fetal chromosomal abnormalities. One of the reasons preventing hospitals and diagnostic centers from offering non-invasive prenatal screening (NIPS) services is the immense demand for hospitals to offer services to COVID-19 patients. On the other hand, COVID-19 lockdown has also brought NIPT to the mainstream. It provides high-accuracy screening with a low risk of infection than invasive procedures like amniocentesis and chorionic villus sampling (CVS). In addition, multiple research trials are being performed to assess the effect of COVID-19 on the market for non-invasive prenatal testing. During the COVID pandemic, in-vitro diagnostics manufacturers and clinical testing laboratories collaborate with research organizations to assess the impact of SARS-CoV-2 infection on pregnancy and congenital disabilities in newborns the need for non-invasive prenatal testing. As a result, the industry experienced a short-term sales decline in 2020, causing a change in business focus and a delay in product launches. Thus COVID-19 outbreak has had only a minor effect on the market for non-invasive prenatal testing (NIPT). 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Instruments, Methods, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global non-invasive prenatal testing market has been segmented and sub-segmented based on the instruments, methods, application, end-user, and region.

Non-Invasive Prenatal Testing Market - By Instruments:

  • Ultrasound
  • NGS
  • PCR
  • Microarray

Based on the instruments, the ultrasound segment is expected to lead the market with the highest share during the forecast period due to the increased number of tests and products for NIPT and growing awareness among pregnant women.

Non-Invasive Prenatal Testing Market - By Method:

  • FCMB
  • Cf-DNA

Based on the method, the cf-DNA segment is accounted for the largest share market, and it is to advance technology; this is the most considerable market value. FCMB segment is projected to have rapid growth in the NIPT market.

Non-Invasive Prenatal Testing Market - By Application:

  • Trisomy
  • Microdeletion
  • Genetics
  • Rh factor

Based on the application, the Trisomy segment holds the most massive value of the overall NIPT market. Increasing occurrences of maternal age and the low cost of NIPT methods enhance the demand of the Global Non-Invasive Prenatal Testing Market.

Non-Invasive Prenatal Testing Market - By End-users:

  • Hospital
  • Diagnostic Labs

Based on end-users, the diagnostic labs account for the largest share of the NIPT market by using a well-supply of necessary items and expert technicians. Government agencies' significant investments to improve healthcare infrastructure also accelerate the demand of the Global Non-Invasive Prenatal Testing Market.

Non-Invasive Prenatal Testing Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America is forecasted to lead the Global Non-Invasive Prenatal Testing Market during the forecast period, with the U.S. accounting for a significant share. North America’s lead is driven by high-end technology; it is a developed market combined with the growing incidence of genetic abnormalities. U.S and Canada are the major countries contributing to the NIPT market. Among these, the United States is ruling the market in this region.

The European market is the second-largest regional market in the global non-invasive prenatal testing market share, owing to the rising awareness and establishment of MIPT procedures. The growing occurrence rate of miscarriages and difficulties, increasing acceptance among pregnant women as a secured alternative to amniocentesis, and awareness of prenatal genetic issues further accelerate the European NIPT market growth.

However, Asia-Pacific is estimated to grow at the highest CAGR during the forecast period, majorly because of exponentially greater population numbers.

The NIPT market for Latin America is projected to grow at a stable rate during the forecast period due to the Y-O-Y growth in the genetic disorders scattered among a vast population base. Increasing awareness about genetic abnormalities is escalated to drive the NIPT market.

The Middle East & Africa for non-invasive prenatal testing is projected to grow at a sluggish CAGR from 2020 to 2025. Launch of new and more advanced NIPT products and their availability and increasing importance for non-invasive techniques over invasive ones fuel this region's market.

KEY MARKET PARTICIPANTS:

Some of the most promising companies holding a significant share in the Global Non-Invasive Prenatal Testing Market profiled in this report are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.) and Beijing Genomics Institute (China).

RECENT MARKET DEVELOPMENTS:

  • On June 04, 2019, Illumina, Inc. introduced the new version of VeriSeq non-invasive prenatal testing solution2, a CE –IVD, next-generation sequencing-based approach that provides exact information regarding fetal chromosomal status early as 10weeks of gestation using a single maternal blood draw. 
  • On July 10, 2018, PerkinElmer announced that it is collaborating with Women & Infant’s Hospital of Rhode Island to estimate an innovative test method using the Vanadis NIPT system, which is under development currently not available in clinical use in the United States.
  • On June 08, 2017, LifeCodexx AG partnered with Life-Cell to introduce Non-Invasive prenatal testing in India, leading baby, and mother safety healthcare providers to bring PrenaTest qNIPTTM for the first time in India.  

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Non-Invasive Prenatal Testing Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  3. Global Ultrasound Market, By Region, From 2021 to 2026 (USD Million)
  4. Global NGS Market, By Region, From 2021 to 2026 (USD Million)
  5. Global PCR Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Microarray Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  8. Global FCMB Market, By Region, From 2021 to 2026 (USD Million)
  9. Global cf-DNA Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  11. Global Trisomy Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Microdeletion Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Genetics Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Rh Factor Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  16. Global Hospital Market, By Region, From 2021 to 2026 (USD Million)
  17. Global Diagnostic Labs Market, By Region, From 2021 to 2026 (USD Million)
  18. North America Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  19. North America Ultrasound Market, By Region, From 2021 to 2026 (USD Million)
  20. North America NGS Market, By Region, From 2021 to 2026 (USD Million)
  21. North America PCR Market, By Region, From 2021 to 2026 (USD Million)
  22. North America Microarray Market, By Region, From 2021 to 2026 (USD Million)
  23. North America Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  24. North America FCMB Market, By Region, From 2021 to 2026 (USD Million)
  25. North America cf-DNA Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  27. North America Trisomy Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Microdeletion Market, By Region, From 2021 to 2026 (USD Million)
  29. North America Genetics Market, By Region, From 2021 to 2026 (USD Million)
  30. North America Rh Factor Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  32. North America Hospital Market, By Region, From 2021 to 2026 (USD Million)
  33. North America Diagnostic Labs Market, By Region, From 2021 to 2026 (USD Million)
  34. United States Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  35. United States Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  36. United States Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  37. United States Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  38. Canada Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  39. Canada Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  40. Canada Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  41. Canada Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  42. Europe Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  43. Europe Ultrasound Market, By Region, From 2021 to 2026 (USD Million)
  44. Europe NGS Market, By Region, From 2021 to 2026 (USD Million)
  45. Europe PCR Market, By Region, From 2021 to 2026 (USD Million)
  46. Europe Microarray Market, By Region, From 2021 to 2026 (USD Million)
  47. Europe Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  48. Europe FCMB Market, By Region, From 2021 to 2026 (USD Million)
  49. Europe cf-DNA Market, By Region, From 2021 to 2026 (USD Million)
  50. Europe Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  51. Europe Trisomy Market, By Region, From 2021 to 2026 (USD Million)
  52. Europe Microdeletion Market, By Region, From 2021 to 2026 (USD Million)
  53. Europe Genetics Market, By Region, From 2021 to 2026 (USD Million)
  54. Europe Rh Factor Market, By Region, From 2021 to 2026 (USD Million)
  55. Europe Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  56. Europe Hospital Market, By Region, From 2021 to 2026 (USD Million)
  57. Europe Diagnostic Labs Market, By Region, From 2021 to 2026 (USD Million)
  58. U.K. Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  59. U.K. Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  60. U.K. Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  61. U.K. Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  62. Germany Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  63. Germany Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  64. Germany Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  65. Germany Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  66. France Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  67. France Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  68. France Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  69. France Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  70. Italy Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  71. Italy Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  72. Italy Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  73. Italy Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  74. Spain Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  75. Spain Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  76. Spain Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  77. Spain Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  78. Asia-Pacific Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  79. Asia-Pacific Ultrasound Market, By Region, From 2021 to 2026 (USD Million)
  80. Asia-Pacific NGS Market, By Region, From 2021 to 2026 (USD Million)
  81. Asia-Pacific PCR Market, By Region, From 2021 to 2026 (USD Million)
  82. Asia-Pacific Microarray Market, By Region, From 2021 to 2026 (USD Million)
  83. Asia-Pacific Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  84. Asia-Pacific FCMB Market, By Region, From 2021 to 2026 (USD Million)
  85. Asia-Pacific cf-DNA Market, By Region, From 2021 to 2026 (USD Million)
  86. Asia-Pacific Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  87. Asia-Pacific Trisomy Market, By Region, From 2021 to 2026 (USD Million)
  88. Asia-Pacific Microdeletion Market, By Region, From 2021 to 2026 (USD Million)
  89. Asia-Pacific Genetics Market, By Region, From 2021 to 2026 (USD Million)
  90. Asia-Pacific Rh Factor Market, By Region, From 2021 to 2026 (USD Million)
  91. Asia-Pacific Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  92. Asia-Pacific Hospital Market, By Region, From 2021 to 2026 (USD Million)
  93. Asia-Pacific Diagnostic Labs Market, By Region, From 2021 to 2026 (USD Million)
  94. Japan Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  95. Japan Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  96. Japan Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  97. Japan Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  98. China Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  99. China Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  100. China Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  101. China Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  102. India Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  103. India Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  104. India Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  105. India Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  106. Australia Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  107. Australia Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  108. Australia Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  109. Australia Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  110. South Korea Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  111. South Korea Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  112. South Korea Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  113. South Korea Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  114. Latin America Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  115. Latin America Ultrasound Market, By Region, From 2021 to 2026 (USD Million)
  116. Latin America NGS Market, By Region, From 2021 to 2026 (USD Million)
  117. Latin America PCR Market, By Region, From 2021 to 2026 (USD Million)
  118. Latin America Microarray Market, By Region, From 2021 to 2026 (USD Million)
  119. Latin America Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  120. Latin America FCMB Market, By Region, From 2021 to 2026 (USD Million)
  121. Latin America cf-DNA Market, By Region, From 2021 to 2026 (USD Million)
  122. Latin America Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  123. Latin America Trisomy Market, By Region, From 2021 to 2026 (USD Million)
  124. Latin America Microdeletion Market, By Region, From 2021 to 2026 (USD Million)
  125. Latin America Genetics Market, By Region, From 2021 to 2026 (USD Million)
  126. Latin America Rh Factor Market, By Region, From 2021 to 2026 (USD Million)
  127. Latin America Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  128. Latin America Hospital Market, By Region, From 2021 to 2026 (USD Million)
  129. Latin America Diagnostic Labs Market, By Region, From 2021 to 2026 (USD Million)
  130. Brazil Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  131. Brazil Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  132. Brazil Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  133. Brazil Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  134. Argentina Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  135. Argentina Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  136. Argentina Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  137. Argentina Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  138. Mexico Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  139. Mexico Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  140. Mexico Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  141. Mexico Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  142. Rest of Latin America Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  143. Rest of Latin America Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  144. Rest of Latin America Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  145. Rest of Latin America Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  146. Middle East & Africa Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  147. Middle East & Africa Ultrasound Market, By Region, From 2021 to 2026 (USD Million)
  148. Middle East & Africa NGS Market, By Region, From 2021 to 2026 (USD Million)
  149. Middle East & Africa PCR Market, By Region, From 2021 to 2026 (USD Million)
  150. Middle East & Africa Microarray Market, By Region, From 2021 to 2026 (USD Million)
  151. Middle East & Africa Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  152. Middle East & Africa FCMB Market, By Region, From 2021 to 2026 (USD Million)
  153. Middle East & Africa cf-DNA Market, By Region, From 2021 to 2026 (USD Million)
  154. Middle East & Africa Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  155. Middle East & Africa Trisomy Market, By Region, From 2021 to 2026 (USD Million)
  156. Middle East & Africa Microdeletion Market, By Region, From 2021 to 2026 (USD Million)
  157. Middle East & Africa Genetics Market, By Region, From 2021 to 2026 (USD Million)
  158. Middle East & Africa Rh Factor Market, By Region, From 2021 to 2026 (USD Million)
  159. Middle East & Africa Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  160. Middle East & Africa Hospital Market, By Region, From 2021 to 2026 (USD Million)
  161. Middle East & Africa Diagnostic Labs Market, By Region, From 2021 to 2026 (USD Million)
  162. Middle East Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  163. Middle East Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  164. Middle East Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  165. Middle East Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)
  166. Africa Non-Invasive Prenatal Testing Market, By Instruments, From 2021 to 2026 (USD Million)
  167. Africa Non-Invasive Prenatal Testing Market, By Method, From 2021 to 2026 (USD Million)
  168. Africa Non-Invasive Prenatal Testing Market, By Application, From 2021 to 2026 (USD Million)
  169. Africa Non-Invasive Prenatal Testing Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample